Funding Rounds
LoQus23 Series A Round, October 2024
LoQus23LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.
Summary
Stage: Series A
Raised Amount: $43.00M
Raised Date: 2024-10-02
Stage: Series A
Raised Amount: $43.00M
Raised Date: 2024-10-02